L

Lexeo Therapeutics Inc
NASDAQ:LXEO

Watchlist Manager
Lexeo Therapeutics Inc
NASDAQ:LXEO
Watchlist
Price: 9.61 USD -3.22% Market Closed
Market Cap: 701.4m USD

Operating Margin
Lexeo Therapeutics Inc

0%
Current
0%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-113.5m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Lexeo Therapeutics Inc
Glance View

Market Cap
701.4m USD
Industry
Biotechnology

Lexeo Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in New York City, New York and currently employs 53 full-time employees. The company went IPO on 2023-11-03. Lexeo Therapeutics, Inc. is a clinical-stage genetic medicine company. The firm has developed a number of disease-modifying gene therapy candidates to treat larger-rare cardiovascular diseases that have unmet need and no approved treatments that address the underlying genetic cause of the disease. These programs include: LX2006, LX2020, LX2021, and LX2022. LX2006 is a gene therapy candidate designed to intravenously deliver a functional frataxin (FXN), a gene for the treatment of Friedreich’s ataxia (FA) cardiomyopathy. LX2020 is a gene therapy candidate designed to intravenously deliver a functional PKP2 gene to cardiac muscle for the treatment of PKP2-ACM. LX2021 is a gene therapy candidate developing to intravenously deliver the coding sequence for the functional connexin 43 (Cx43) protein for a group of inherited cardiac muscle disorders. LX2022 delivers a functional TNNI3 gene to myocardial cells to treat a distinct form of hypertrophic cardiomyopathy (HCM).

LXEO Intrinsic Value
0.69 USD
Overvaluation 93%
Intrinsic Value
Price
L
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-113.5m
/
Revenue
0
What is the Operating Margin of Lexeo Therapeutics Inc?

Based on Lexeo Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top